We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Genedata Provides Expressionist Platform to Eisai Research Institute
News

Genedata Provides Expressionist Platform to Eisai Research Institute

Genedata Provides Expressionist Platform to Eisai Research Institute
News

Genedata Provides Expressionist Platform to Eisai Research Institute

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Genedata Provides Expressionist Platform to Eisai Research Institute"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genedata has announced an agreement with the Eisai Research Institute (ERI) for the company’s Genedata Expressionist® biomarker discovery platform.

Genedata Expressionist is a modular computational platform for biomarker discovery that integrates transcriptomics, proteomics and metabolomics data within a single enterprise software system.

With sophisticated high-throughput data processing and automated workflows for quality assessment, statistical analysis and interpretation functionalities, the platform provides a single-point-of-access for all experimental data, including sample information, raw and pre-processed data, analysis results and documentation with reports.

Jens Hoefkens, Managing Director of Genedata Inc., said, “We are very pleased to be working with the Eisai Research Institute in meeting its bio-IT infrastructure needs for biomarker validation. As the latest of an increasing series of Expressionist installations, we view the institute’s choice as further validation of Expressionist’s appeal to researchers seeking a common platform of tools and applications for biomarker identification with stringent quality control and open data sharing.”

Advertisement